Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, describes different methods dermatologists can use to treat atopic dermatitis (AD).
Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, listed a variety of tools that dermatologists should have in their toolbox to treat atopic dermatitis (AD), including topical medications and non-pharmacologic lifestyle changes.
At the 2023 Fall Clinical Dermatology Conference, Lio presented his session titled, "Closing the Healthcare Gaps in the Management of Moderate to Severe Atopic Dermatitis With Biologics."
Transcript
What are some of the new tools dermatologists can use to treat atopic dermatitis?
There are so many tools that we can add to our toolbox for treating atopic dermatitis and other conditions. Of course, we have our topical medications, and there are some really exciting new ones for atopic derm. Some non-steroidal agents are going to break the mold, and for me have already broken the mold, and I'm excited for clinicians who haven't really experimented with them or been exposed to them yet with their patients because I think they will find that they can solve a lot of our problems.
There are some new oral medications that are exciting for patients who are really stuck. We finally have some FDA-approved systemic treatments and our JAK inhibitors. We also, of course, have some biologic agents, some that have been around for a few years, but new ones that are coming; in fact, one is around the corner. We have some excitement on all of these fronts and I think we can pull everything together.
Plus, for those who know me, the other side of my life is thinking about integrative approaches, and there are a lot of fascinating things we can do that are non-pharmacologic. Lifestyle changes, botanical changes, things like that, we can use things to help patients who maybe don't require a prescription but still can do something. Sometimes, even behavioral interventions. I've been interested in things like habit reversal therapy and some of these different approaches to the mind-body connection, which play a huge role in atopic dermatitis.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More